Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Francesca Dughera"'
Autor:
Soraya Puglisi, Alessandro Rossini, Roberta Poli, Francesca Dughera, Anna Pia, Massimo Terzolo, Giuseppe Reimondo
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
Sodium-glucose cotransporters inhibitors (SGLT2-i) and GLP-1 receptor agonists (GLP1-RA) are glucose-lowering drugs that are proved to reduce the cardiovascular (CV) risk in type 2 diabetes mellitus (T2DM). In this process, the renin-angiotensin-aldo
Externí odkaz:
https://doaj.org/article/cd1fcb24822545a692d43b8491dccd8b
Autor:
Massimo Terzolo, Giuseppe Reimondo, A. Rossini, Francesco Ferraù, S. Cannavò, Anna Pia, Marta Ragonese, Soraya Puglisi, Giorgio Borretta, A. Latina, A. Parisi, Isabella Tabaro, Micaela Pellegrino, Francesca Dughera
Publikováno v:
Journal of Endocrinological Investigation
Purpose The impact of patient’s characteristics on glucocorticoid (GC) replacement therapy in adrenal insufficiency (AI) is poorly evaluated. Aims of this study were to assess the influence of sex and body weight on GC dosing and to describe the ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34a5dd33aae9bc92dc523505623a9204
http://europepmc.org/articles/PMC7946659
http://europepmc.org/articles/PMC7946659
Autor:
Alessandro Rossini, Massimo Terzolo, Francesca Dughera, Roberta Poli, Anna Pia, Soraya Puglisi, Giuseppe Reimondo
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
Frontiers in Endocrinology
Frontiers in Endocrinology
Sodium-glucose cotransporters inhibitors (SGLT2-i) and GLP-1 receptor agonists (GLP1-RA) are glucose-lowering drugs that are proved to reduce the cardiovascular (CV) risk in type 2 diabetes mellitus (T2DM). In this process, the renin-angiotensin-aldo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df43671cf353d8e3362ca7b986383989
https://www.frontiersin.org/articles/10.3389/fendo.2021.738848/full
https://www.frontiersin.org/articles/10.3389/fendo.2021.738848/full
Autor:
Gian Paolo Caviglia, Marco Astegiano, Sharmila Fagoonee, Chiara Rosso, Francesca Dughera, Davide Giuseppe Ribaldone, Rinaldo Pellicano
Publikováno v:
Minerva biotecnologica (Testo stamp.) 31 (2019): 83–92. doi:10.23736/S1120-4826.19.02554-0
info:cnr-pdr/source/autori:Caviglia G.P.; Rosso C.; Ribaldone D.G.; Dughera F.; Fagoonee S.; Astegiano M.; Pellicano R./titolo:Physiopathology of intestinal barrier and the role of zonulin/doi:10.23736%2FS1120-4826.19.02554-0/rivista:Minerva biotecnologica (Testo stamp.)/anno:2019/pagina_da:83/pagina_a:92/intervallo_pagine:83–92/volume:31
info:cnr-pdr/source/autori:Caviglia G.P.; Rosso C.; Ribaldone D.G.; Dughera F.; Fagoonee S.; Astegiano M.; Pellicano R./titolo:Physiopathology of intestinal barrier and the role of zonulin/doi:10.23736%2FS1120-4826.19.02554-0/rivista:Minerva biotecnologica (Testo stamp.)/anno:2019/pagina_da:83/pagina_a:92/intervallo_pagine:83–92/volume:31
The intestinal epithelium with its barrier function controls the antigen trafficking from the intestinal lumen to the submucosa. Zonulin, a precursor of haptoglobin-2, plays a key role in maintaining the homeostasis of the intestinal mucosa through t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c59a5f0c01b19fef81da38724c401c7e
http://hdl.handle.net/2318/1707540
http://hdl.handle.net/2318/1707540
